Logo image of CCL

CARNIVAL CORP (CCL) Stock Fundamental Analysis

USA - NYSE:CCL - PA1436583006 - Common Stock

31.19 USD
-0.01 (-0.03%)
Last: 9/17/2025, 8:04:00 PM
31.3 USD
+0.11 (+0.35%)
After Hours: 9/17/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, CCL scores 4 out of 10 in our fundamental rating. CCL was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. While CCL is still in line with the averages on profitability rating, there are concerns on its financial health. CCL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CCL had positive earnings in the past year.
In the past year CCL had a positive cash flow from operations.
CCL had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CCL reported negative operating cash flow in multiple years.
CCL Yearly Net Income VS EBIT VS OCF VS FCFCCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.94%, CCL is in the better half of the industry, outperforming 67.67% of the companies in the same industry.
CCL has a better Return On Equity (25.23%) than 81.95% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.71%, CCL is in the better half of the industry, outperforming 69.17% of the companies in the same industry.
Industry RankSector Rank
ROA 4.94%
ROE 25.23%
ROIC 8.71%
ROA(3y)-2.68%
ROA(5y)-8.99%
ROE(3y)-22.2%
ROE(5y)-38.93%
ROIC(3y)N/A
ROIC(5y)N/A
CCL Yearly ROA, ROE, ROICCCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

CCL's Profit Margin of 9.72% is fine compared to the rest of the industry. CCL outperforms 74.44% of its industry peers.
CCL's Profit Margin has declined in the last couple of years.
CCL has a better Operating Margin (16.23%) than 70.68% of its industry peers.
CCL's Operating Margin has declined in the last couple of years.
CCL has a better Gross Margin (53.90%) than 62.41% of its industry peers.
In the last couple of years the Gross Margin of CCL has grown nicely.
Industry RankSector Rank
OM 16.23%
PM (TTM) 9.72%
GM 53.9%
OM growth 3YN/A
OM growth 5Y-1.91%
PM growth 3YN/A
PM growth 5Y-11.81%
GM growth 3YN/A
GM growth 5Y6.74%
CCL Yearly Profit, Operating, Gross MarginsCCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCL is still creating some value.
Compared to 1 year ago, CCL has more shares outstanding
Compared to 5 years ago, CCL has more shares outstanding
CCL has a better debt/assets ratio than last year.
CCL Yearly Shares OutstandingCCL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
CCL Yearly Total Debt VS Total AssetsCCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

CCL has an Altman-Z score of 1.25. This is a bad value and indicates that CCL is not financially healthy and even has some risk of bankruptcy.
CCL has a worse Altman-Z score (1.25) than 61.65% of its industry peers.
CCL has a debt to FCF ratio of 9.71. This is a negative value and a sign of low solvency as CCL would need 9.71 years to pay back of all of its debts.
The Debt to FCF ratio of CCL (9.71) is better than 60.90% of its industry peers.
A Debt/Equity ratio of 2.58 is on the high side and indicates that CCL has dependencies on debt financing.
With a Debt to Equity ratio value of 2.58, CCL perfoms like the industry average, outperforming 45.11% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.58
Debt/FCF 9.71
Altman-Z 1.25
ROIC/WACC1.02
WACC8.57%
CCL Yearly LT Debt VS Equity VS FCFCCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

CCL has a Current Ratio of 0.34. This is a bad value and indicates that CCL is not financially healthy enough and could expect problems in meeting its short term obligations.
CCL has a Current ratio of 0.34. This is amonst the worse of the industry: CCL underperforms 87.22% of its industry peers.
CCL has a Quick Ratio of 0.34. This is a bad value and indicates that CCL is not financially healthy enough and could expect problems in meeting its short term obligations.
CCL has a Quick ratio of 0.30. This is amonst the worse of the industry: CCL underperforms 84.21% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.3
CCL Yearly Current Assets VS Current LiabilitesCCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 148.68% over the past year.
The earnings per share for CCL have been decreasing by -20.70% on average. This is quite bad
The Revenue has grown by 10.82% in the past year. This is quite good.
Measured over the past years, CCL shows a small growth in Revenue. The Revenue has been growing by 3.74% on average per year.
EPS 1Y (TTM)148.68%
EPS 3YN/A
EPS 5Y-20.7%
EPS Q2Q%218.18%
Revenue 1Y (TTM)10.82%
Revenue growth 3Y135.82%
Revenue growth 5Y3.74%
Sales Q2Q%9.46%

3.2 Future

The Earnings Per Share is expected to grow by 19.17% on average over the next years. This is quite good.
Based on estimates for the next years, CCL will show a small growth in Revenue. The Revenue will grow by 4.39% on average per year.
EPS Next Y45.82%
EPS Next 2Y29.97%
EPS Next 3Y24.66%
EPS Next 5Y19.17%
Revenue Next Year6.12%
Revenue Next 2Y4.96%
Revenue Next 3Y4.52%
Revenue Next 5Y4.39%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CCL Yearly Revenue VS EstimatesCCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
CCL Yearly EPS VS EstimatesCCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 4 -4 -6

6

4. Valuation

4.1 Price/Earnings Ratio

CCL is valuated correctly with a Price/Earnings ratio of 16.50.
CCL's Price/Earnings ratio is a bit cheaper when compared to the industry. CCL is cheaper than 75.94% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.20, CCL is valued a bit cheaper.
With a Price/Forward Earnings ratio of 13.38, CCL is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CCL indicates a somewhat cheap valuation: CCL is cheaper than 77.44% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.70. CCL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.5
Fwd PE 13.38
CCL Price Earnings VS Forward Price EarningsCCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCL is valued a bit cheaper than the industry average as 70.68% of the companies are valued more expensively.
83.46% of the companies in the same industry are more expensive than CCL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.58
EV/EBITDA 9.61
CCL Per share dataCCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CCL's earnings are expected to grow with 24.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y29.97%
EPS Next 3Y24.66%

0

5. Dividend

5.1 Amount

CCL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CARNIVAL CORP

NYSE:CCL (9/17/2025, 8:04:00 PM)

After market: 31.3 +0.11 (+0.35%)

31.19

-0.01 (-0.03%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)06-24 2025-06-24/bmo
Earnings (Next)09-29 2025-09-29/amc
Inst Owners65.53%
Inst Owner Change5.83%
Ins Owners7.58%
Ins Owner Change0.42%
Market Cap40.95B
Analysts81.88
Price Target33.49 (7.37%)
Short Float %4.92%
Short Ratio2.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)287.29%
Min EPS beat(2)42.71%
Max EPS beat(2)531.88%
EPS beat(4)4
Avg EPS beat(4)166.46%
Min EPS beat(4)8.2%
Max EPS beat(4)531.88%
EPS beat(8)8
Avg EPS beat(8)188.29%
EPS beat(12)11
Avg EPS beat(12)103.13%
EPS beat(16)11
Avg EPS beat(16)70.73%
Revenue beat(2)2
Avg Revenue beat(2)0.49%
Min Revenue beat(2)0.05%
Max Revenue beat(2)0.93%
Revenue beat(4)2
Avg Revenue beat(4)0%
Min Revenue beat(4)-0.88%
Max Revenue beat(4)0.93%
Revenue beat(8)5
Avg Revenue beat(8)0.18%
Revenue beat(12)7
Avg Revenue beat(12)-0.92%
Revenue beat(16)7
Avg Revenue beat(16)-5.53%
PT rev (1m)2.07%
PT rev (3m)18.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.23%
EPS NY rev (1m)0.17%
EPS NY rev (3m)6.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.87%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)1.7%
Valuation
Industry RankSector Rank
PE 16.5
Fwd PE 13.38
P/S 1.58
P/FCF 14.58
P/OCF 7.54
P/B 4.09
P/tB 4.96
EV/EBITDA 9.61
EPS(TTM)1.89
EY6.06%
EPS(NY)2.33
Fwd EY7.47%
FCF(TTM)2.14
FCFY6.86%
OCF(TTM)4.14
OCFY13.27%
SpS19.78
BVpS7.62
TBVpS6.28
PEG (NY)0.36
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.94%
ROE 25.23%
ROCE 11.02%
ROIC 8.71%
ROICexc 9.23%
ROICexgc 9.7%
OM 16.23%
PM (TTM) 9.72%
GM 53.9%
FCFM 10.81%
ROA(3y)-2.68%
ROA(5y)-8.99%
ROE(3y)-22.2%
ROE(5y)-38.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-0.03%
ROICexc growth 3YN/A
ROICexc growth 5Y1.43%
OM growth 3YN/A
OM growth 5Y-1.91%
PM growth 3YN/A
PM growth 5Y-11.81%
GM growth 3YN/A
GM growth 5Y6.74%
F-Score8
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 2.58
Debt/FCF 9.71
Debt/EBITDA 3.76
Cap/Depr 98.91%
Cap/Sales 10.11%
Interest Coverage 250
Cash Conversion 79.09%
Profit Quality 111.21%
Current Ratio 0.34
Quick Ratio 0.3
Altman-Z 1.25
F-Score8
WACC8.57%
ROIC/WACC1.02
Cap/Depr(3y)178.87%
Cap/Depr(5y)171.94%
Cap/Sales(3y)24.77%
Cap/Sales(5y)65.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)148.68%
EPS 3YN/A
EPS 5Y-20.7%
EPS Q2Q%218.18%
EPS Next Y45.82%
EPS Next 2Y29.97%
EPS Next 3Y24.66%
EPS Next 5Y19.17%
Revenue 1Y (TTM)10.82%
Revenue growth 3Y135.82%
Revenue growth 5Y3.74%
Sales Q2Q%9.46%
Revenue Next Year6.12%
Revenue Next 2Y4.96%
Revenue Next 3Y4.52%
Revenue Next 5Y4.39%
EBIT growth 1Y48.24%
EBIT growth 3YN/A
EBIT growth 5Y1.76%
EBIT Next Year96.77%
EBIT Next 3Y29.84%
EBIT Next 5Y19.31%
FCF growth 1Y215.65%
FCF growth 3YN/A
FCF growth 5Y94.16%
OCF growth 1Y411.29%
OCF growth 3YN/A
OCF growth 5Y1.58%